Procarbazine and CCNU as initial treatment in gliomatosis cerebri

Oncology

Volumn 75, Issue 3-4, 2008, Pages 182-185

  Glas, Martin ^a   Rasch, Katja ^a   Wiewrodt, Dorothee ^b   Weller, Michael ^c,d   Herrlinger, Ulrich ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Brain tumors; CCNU; Chemotherapy; Gliomatosis cerebri; Procarbazine

Indexed keywords

LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GLIOMA; GLIOMATOSIS CEREBRI; HEMATOLOGIC DISEASE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SALVAGE THERAPY; SKIN ALLERGY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LOMUSTINE; MALE; MIDDLE AGED; NEOPLASMS, NEUROEPITHELIAL; PILOT PROJECTS; PROCARBAZINE; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 54749092947     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000163057     Document Type: Article

References (12)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109.
2. Elshaikh MA, Stevens GH, Peereboom DM, Cohen BH, Prayson RA, Lee SY, Barnett GH, Suh JH: Gliomatosis cerebri: treatment results with radiotherapy alone. Cancer 2002;95:2027-2031.
3. Levin N, Gomori JM, Siegal T: Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide. Neurology 2004;63:354-356.
4. Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY, ANOCEF group: Initial chemotherapy in gliomatosis cerebri. Neurology 2004;63:270-275.
5. Herrlinger U, Felsberg J, Küker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M: Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol 2002;52:390-399.
6. Kellie SJ, Barbaric D, Koopmans P, Earl J, Carr DJ, de Graaf SS: Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing: a surrogate marker of brain penetration. Cancer 2002;94:1815-1820.
7. Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH, Choi KS, Cho BK: Gliomatosis cerebri: clinical features, treatment, and prognosis. Acta Neurochir 1998;140:755-762.
8. Horst E, Micke O, Romppainen ML, Pyhtinen J, Paulus W, Schäfer U, Rübe C, Willich N: Radiation therapy approach in gliomatosis cerebri - case reports and literature review. Acta Oncol 2000;39:747-751.
9. Perkins GH, Schomer DF, Fuller GN, Allen PK, Maor MH: Gliomatosis cerebri: improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys 2003;56:1137-1146.
10. Taillibert S, Chodkiewicz C, Laigle-Donadey F, Napolitano M, Cartalat-Carel S, Sanson M: Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature. J Neurooncol 2006;76:201-205.
11. Crossen JR, Garwood D, Glatstein E, Neuwelt EA: Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 1994;12:627-642.
12. Soffietti R, RudàR, Laguzzi E, Butolo L, Pace A, Carapella C, Riva M, Salvati M, Silvani A, Caroli M: Treatment of gliomatosis cerebri with temozolomide: a retrospective study of the AINO (Italian Association for Neuro-Oncology). 2007 ASCO Annu Meet Proc, part I, vol 25, No 18S. J Clin Oncol 2007: 2033.